A team of Kyoto University said Monday it has applied for approval by the health ministry of a plan to infuse platelets made from induced pluripotent stem cells into a sufferer of a serious blood disease.
A team of Kyoto University said Monday it has applied for approval by the health ministry of a plan to infuse platelets made from induced pluripotent stem cells into a sufferer of a serious blood disease.
The team, led by Prof. Koji Eto, filed the application last month after obtaining permission for the iPS cell-based clinical study from the university’s screening committee in May, it said at a press conference in Kyoto. A panel of the ministry is scheduled to discuss the plan on Aug.
